In the tumor region, the frequencies of CD3+ T cells and CD8+ T cells were significantly elevated in EBVaGLELC compared with GAC (p = 0.0246 and p = 0.0003, respectively, Figure 4). This evidence concerns the gene CD8A and neoplasm.